Search Results - "Burke, Amy C"
-
1
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis
Published in Annual review of nutrition (17-07-2016)“…Citrus flavonoids are polyphenolic compounds with significant biological properties. This review summarizes recent advances in understanding the ability of…”
Get full text
Journal Article -
2
Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice
Published in Journal of lipid research (01-09-2018)“…Obesity and its associated metabolic dysfunction and cardiovascular disease risk represent a leading cause of adult morbidity worldwide. Currently available…”
Get full text
Journal Article -
3
The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S]
Published in Journal of lipid research (01-03-2020)“…Obesity, dyslipidemia, and insulin resistance, the increasingly common metabolic syndrome, are risk factors for CVD and type 2 diabetes that warrant novel…”
Get full text
Journal Article -
4
Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21
Published in Endocrinology (Philadelphia) (01-06-2015)“…The molecular mechanisms and metabolic pathways whereby the citrus flavonoid, naringenin, reduces dyslipidemia and improves glucose tolerance were investigated…”
Get full text
Journal Article -
5
ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia
Published in Current opinion in lipidology (01-04-2017)“…ATP-citrate lyase (ACLY) has re-emerged as a drug target for LDL cholesterol (LDL-C) lowering. We review ACLY as a therapeutic strategy, its genetics, its…”
Get full text
Journal Article -
6
Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis
Published in Current opinion in lipidology (01-02-2019)“…Bempedoic acid has emerged as a potent inhibitor of ATP-citrate lyase (ACLY), a target for the reduction of LDL cholesterol (LDL-C). We review the impact of…”
Get full text
Journal Article -
7
PCSK9: Regulation and Target for Drug Development for Dyslipidemia
Published in Annual review of pharmacology and toxicology (06-01-2017)“…Proprotein convertase subtilisin kexin type-9 (PCSK9) is a secreted zymogen expressed primarily in the liver. PCSK9 circulates in plasma, binds to cell surface…”
Get full text
Journal Article -
8
Regression of atherosclerosis: lessons learned from genetically modified mouse models
Published in Current opinion in lipidology (01-04-2018)“…Regression, or reversal, of atherosclerosis has become an important clinical objective. The development of consistent models of murine atherosclerosis…”
Get full text
Journal Article -
9
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr−/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid
Published in Arteriosclerosis, thrombosis, and vascular biology (01-04-2017)“…OBJECTIVE—Bempedoic acid (ETC-1002, 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid) is a novel low-density lipoprotein cholesterol–lowering compound. In…”
Get full text
Journal Article -
10
Regulation of Stress Granule Formation by Inflammation, Vascular Injury, and Atherosclerosis
Published in Arteriosclerosis, thrombosis, and vascular biology (01-10-2019)“…OBJECTIVE:Stress granules (SGs) are dynamic cytoplasmic aggregates containing mRNA, RNA-binding proteins, and translation factors that form in response to…”
Get full text
Journal Article -
11
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient (LDLR+/− and LDLR−/−) Yucatan Miniature Pigs
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…OBJECTIVE—Bempedoic acid (BemA; ETC-1002) is a novel drug that targets hepatic ATP-citrate lyase to reduce cholesterol biosynthesis. In phase 2 studies, BemA…”
Get full text
Journal Article -
12
Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair‐Fed Ldlr−/− Mice
Published in Molecular nutrition & food research (01-03-2019)“…Scope Naringenin is a citrus‐derived flavonoid that has potent lipid‐lowering and insulin‐sensitizing effects in obese mouse models of metabolic dysfunction…”
Get full text
Journal Article -
13
Exploring the role of place in sex work through participant photography
Published in Sexualities (01-02-2024)“…In this article, the authors explore the place-based experiences of sex workers and how these experiences intersect with the juridical realm of sex work. The…”
Get full text
Journal Article -
14
Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr−/− mice
Published in Atherosclerosis (01-07-2019)“…Naringenin is a citrus-derived flavonoid with lipid-lowering and insulin-sensitizing effects leading to athero-protection in Ldlr−/− mice fed a high-fat diet…”
Get full text
Journal Article -
15
Supporting positive sexual health for persons with developmental disabilities: Stories about the right to love
Published in British journal of learning disabilities (01-12-2019)“…Accessible Summary This research is about the sexual rights of persons with developmental disabilities. For 12 months, nine adults with developmental…”
Get full text
Journal Article -
16
Peroxisome Proliferator–Activated Receptor δ Agonist GW1516 Attenuates Diet-Induced Aortic Inflammation, Insulin Resistance, and Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
Published in Arteriosclerosis, thrombosis, and vascular biology (01-01-2014)“…OBJECTIVE—The peroxisome proliferator–activated receptor (PPAR) δ regulates systemic lipid homeostasis and inflammation. However, the ability of PPARδ agonists…”
Get full text
Journal Article -
17
Abstract 369: Naringenin Supplementation to a Chow Diet Reduces Plasma Lipids and Adiposity, and Suppresses Rer In Ldlr -/- Mice Fed a Chow Diet
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2017)“…Abstract only Previously, we have shown that intervention by the addition of the citrus flavonoid naringenin to a chow diet enhances the reversal of…”
Get full text
Journal Article -
18
Abstract 95: Naringenin Supplementation of a Low-Fat Diet Enhances the Reversal of Metabolic Dysfunction, Promotes Atherosclerosis Regression and Improves Lesion Pathology in Ldlr -/- Mice
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2016)“…Abstract only Diet-induced metabolic dysregulation (MetS) and atherosclerosis in mouse models can be reversed by intervention with a low-fat diet…”
Get full text
Journal Article -
19
Abstract 686: Intervention with Naringenin Enhances Weight Loss, Potentiates Improvements in Metabolic Dysregulation and Halts Progression of Atherosclerosis Induced by a High-Fat Diet in LDLr-/- Mice
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2015)“…Abstract only Previous studies demonstrate that the addition of naringenin, a grapefruit flavonoid, to a high-fat diet prevents the development of many…”
Get full text
Journal Article -
20
Abstract 394: Ldl-cholesterol, ApoB100 Kinetics and Atherosclerosis in Ldlr-deficient Yucatan Minipigs: A New Model for Familial Hypercholesterolemia
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2017)“…Abstract only Lack of animal models with human-like lipoprotein metabolism and pathology has hampered translational research in atherosclerosis. Recently, a…”
Get full text
Journal Article